About Thyrocare Technologies Ltd
Thyrocare Technologies operates in the healthcare industry and is involved in providing quality diagnostic services to patients.
Founded
2000
CEO
Rahul Franklin Guha
Employees
2,092
HQ
Navi Mumbai, India
Finished Products
1Diagnostic Services
₹1,956.18Cr2Sale of Services
₹1,387.18Cr3Sale of Consumables for Provid
₹49.34Cr4Other Operating Revenues
₹38.25Cr5Trading Goods
₹12.02Cr6Sale of Products
₹10.68CrRaw Materials
1Raw Material Consumed
₹541.04Cr2Reagents/Diagnostic Material
₹266.17Cr3Consumables-Laboartory
₹30.44Cr4Consumables-Processing
₹15.25Cr5Purchases
₹11.66Cr6Glucose Strips
₹4.32CrAbout Thyrocare Technologies Ltd
Thyrocare Technologies operates in the healthcare industry and is involved in providing quality diagnostic services to patients.
Founded:2000
CEO:Rahul Franklin Guha
Employees:2,092
HQ:Navi Mumbai, India
Finished Products
1Diagnostic Services
₹1,956.18Cr2Sale of Services
₹1,387.18Cr3Sale of Consumables for Provid
₹49.34Cr4Other Operating Revenues
₹38.25Cr5Trading Goods
₹12.02Cr6Sale of Products
₹10.68CrRaw Materials
1Raw Material Consumed
₹541.04Cr2Reagents/Diagnostic Material
₹266.17Cr3Consumables-Laboartory
₹30.44Cr4Consumables-Processing
₹15.25Cr5Purchases
₹11.66Cr6Glucose Strips
₹4.32CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹662
52W Low
₹343
Volume344.77K
Avg VolumeN/A
Beta0.50
Dividend Yield2.37%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
53.46x
Valuation
P/B Ratio
18.34x
Valuation
EPS
₹11.05
Valuation
Dividend Yield
2.37%
Valuation
ROE
27.85%
Profitability
ROCE
33.90%
Profitability
Revenue by Segment
Contribution & growth by business line
Diagnostic Testing Services
+22.7%93.2%
₹772.53 Cr
Imaging Services
-2.1%6.4%
₹53.14 Cr
Others
+0.0%0.4%
₹3.37 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
99.7%
International
0.3%
India99.7%
Tanzania0.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.09x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
13.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.